1. Home
  2. ANGI vs ORGO Comparison

ANGI vs ORGO Comparison

Compare ANGI & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Angi Inc.

ANGI

Angi Inc.

HOLD

Current Price

$12.02

Market Cap

488.0M

ML Signal

HOLD

Logo Organogenesis Holdings Inc.

ORGO

Organogenesis Holdings Inc.

HOLD

Current Price

$5.03

Market Cap

539.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANGI
ORGO
Founded
1995
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
488.0M
539.1M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
ANGI
ORGO
Price
$12.02
$5.03
Analyst Decision
Buy
Buy
Analyst Count
7
3
Target Price
$18.20
$8.00
AVG Volume (30 Days)
1.3M
3.1M
Earning Date
11-04-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
13.43
N/A
EPS
0.72
N/A
Revenue
$1,057,636,000.00
$465,218,000.00
Revenue This Year
N/A
$2.51
Revenue Next Year
$4.89
$25.45
P/E Ratio
$16.71
N/A
Revenue Growth
N/A
2.24
52 Week Low
$10.25
$2.61
52 Week High
$20.70
$7.08

Technical Indicators

Market Signals
Indicator
ANGI
ORGO
Relative Strength Index (RSI) 50.25 48.23
Support Level $11.20 $5.09
Resistance Level $11.61 $5.83
Average True Range (ATR) 0.41 0.41
MACD 0.25 -0.11
Stochastic Oscillator 96.98 6.71

Price Performance

Historical Comparison
ANGI
ORGO

About ANGI Angi Inc.

Angi Inc connects quality home service professionals with consumers across different categories, from repairing and remodeling to cleaning and landscaping. It operates through brands like Angi, HomeAdvisor, and Handy. The company has three operating segments, namely, Ads and Leads, Services, and International (Europe and Canada). A majority of its revenue is generated from the Ads and Leads segment, which provides professionals the capability to engage with potential customers, including quoting and invoicing services, and provides consumers with tools and resources to help them find professionals nationwide for home repair, maintenance, and improvement projects. Geographically, the company derives its key revenue from the United States and also has a presence in other countries.

About ORGO Organogenesis Holdings Inc.

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

Share on Social Networks: